Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63.2M
-
Number of holders
-
123
-
Total 13F shares, excl. options
-
38.3M
-
Shares change
-
+254K
-
Total reported value, excl. options
-
$502M
-
Value change
-
-$36.8M
-
Put/Call ratio
-
0.48
-
Number of buys
-
83
-
Number of sells
-
-65
-
Price
-
$13.11
Significant Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q3 2023
165 filings reported holding TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value as of Q3 2023.
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) has 123 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.3M shares
of 63.2M outstanding shares and own 60.61% of the company stock.
Largest 10 shareholders include ALLIANCEBERNSTEIN L.P. (4.31M shares), VANGUARD GROUP INC (4.19M shares), BlackRock Inc. (3.46M shares), Soleus Capital Management, L.P. (1.91M shares), PERCEPTIVE ADVISORS LLC (1.83M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.79M shares), EMERALD ADVISERS, LLC (1.47M shares), TimesSquare Capital Management, LLC (1.43M shares), CIBC Private Wealth Group, LLC (1.38M shares), and STATE STREET CORP (1.3M shares).
This table shows the top 123 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.